ARCHIVES

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

This article is from The Cancer Letter archive.

Vol. 18 No. 23 | June 5, 1992

Download PDF Visit The Full Archive

Related Articles

Proteomics Used To Find Predictor Of Response In FAP

April 30, 2004

In Brief: Clarke, Einstein Lead ACCC; Changes At CCSG, Cohen Leaves USC For Childhood Foundation

April 17, 1992

Estrogen Alone Didn’t Increase Lung Cancer Mortality In WHI

August 27, 2010

ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number

June 17, 2011

Spartanburg CCOP Makes the List

April 10, 1987

Panel Resumes Deliberations

January 4, 1980